OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
BESA58

Best Agrolife Ltd

Agricultural ChemicalsVerified

Best Agrolife maintains a debt-to-equity ratio of 0.63 and a current ratio of 1.37, indicating moderate leverage and acceptable short-term liquidity. The company's liquidity position is assessed as medium, with free cash flow of INR 83.1 million and negative net cash after subtracting total debt. The return on equity of 9.23% and return on assets of 3.58% suggest that the company is generating returns above the industry median for ROE but below for ROA, indicating room for improvement in asset utilization. The company's profitability is driven by its agrochemical product portfolio, with a gross profit of INR 5.13 billion and operating income of INR 1.59 billion. However, the net income of INR 698.9 million reflects a net margin of 3.85%, which is below the industry median for net margins. The company's capital structure is supported by total equity of INR 7.58 billion and long-term debt of INR 4.78 billion, with a total asset base of INR 19.5 billion. Best Agrolife operates through three business segments: Technicals, Formulations, and Branded Products. The company's revenue is concentrated in India, with no disclosed international revenue breakdown. The Branded Products segment includes well-known insecticide, herbicide, and fungicide brands, which are key to the company's market positioning. The company's revenue growth trajectory is expected to remain stable, with no significant changes in the current fiscal year. The capital expenditure of INR -973.9 million indicates a reduction in investment, which may affect long-term growth potential. The company's outlook for the next fiscal year is neutral, with no projected revenue growth. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's risk score is influenced by its negative net cash position after subtracting total debt. The dilution potential is low, with no significant changes in shares outstanding between basic and diluted shares. Recent events include the company's ESG controversies score of 100.0, indicating high controversy risk, and governance and social pillar scores of 40.3 and 31.7, respectively, which are below industry benchmarks. No recent filings or transcripts have been disclosed that would significantly impact the company's operations or financials.

30-day price · BESA+5.41 (+39.8%)
Low$12.30High$21.20Close$18.99As of12 May, 00:00 UTC
Profile
CompanyBest Agrolife Ltd
TickerBESA.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Best Agrolife Limited is an India-based company that develops and sells agrochemical solutions, including insecticides, herbicides, fungicides, and plant growth regulators, to domestic and international agricultural markets through its Technicals, Formulations, and Branded Products segments.

Classification. Best Agrolife is classified under the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry, with a confidence level of 0.92 based on verified market data.

Best Agrolife maintains a debt-to-equity ratio of 0.63 and a current ratio of 1.37, indicating moderate leverage and acceptable short-term liquidity. The company's liquidity position is assessed as medium, with free cash flow of INR 83.1 million and negative net cash after subtracting total debt. The return on equity of 9.23% and return on assets of 3.58% suggest that the company is generating returns above the industry median for ROE but below for ROA, indicating room for improvement in asset utilization. The company's profitability is driven by its agrochemical product portfolio, with a gross profit of INR 5.13 billion and operating income of INR 1.59 billion. However, the net income of INR 698.9 million reflects a net margin of 3.85%, which is below the industry median for net margins. The company's capital structure is supported by total equity of INR 7.58 billion and long-term debt of INR 4.78 billion, with a total asset base of INR 19.5 billion. Best Agrolife operates through three business segments: Technicals, Formulations, and Branded Products. The company's revenue is concentrated in India, with no disclosed international revenue breakdown. The Branded Products segment includes well-known insecticide, herbicide, and fungicide brands, which are key to the company's market positioning. The company's revenue growth trajectory is expected to remain stable, with no significant changes in the current fiscal year. The capital expenditure of INR -973.9 million indicates a reduction in investment, which may affect long-term growth potential. The company's outlook for the next fiscal year is neutral, with no projected revenue growth. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's risk score is influenced by its negative net cash position after subtracting total debt. The dilution potential is low, with no significant changes in shares outstanding between basic and diluted shares. Recent events include the company's ESG controversies score of 100.0, indicating high controversy risk, and governance and social pillar scores of 40.3 and 31.7, respectively, which are below industry benchmarks. No recent filings or transcripts have been disclosed that would significantly impact the company's operations or financials.
Key takeaways
  • Best Agrolife has a moderate debt-to-equity ratio and acceptable short-term liquidity.
  • The company's return on equity is above the industry median, but return on assets is below.
  • Revenue is concentrated in India, with no disclosed international revenue breakdown.
  • The company's capital expenditure is negative, indicating reduced investment.
  • The company faces high ESG controversy risk and below-average governance and social scores.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$18.14B
Gross profit$5.13B
Operating income$1.59B
Net income$698.9M
R&D
SG&A
D&A
SBC
Operating cash flow$2.28B
CapEx-$973.9M
Free cash flow$83.1M
Total assets$19.50B
Total liabilities$11.92B
Total equity$7.58B
Cash & equivalents
Long-term debt$4.78B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$7.58B
Net cash-$4.78B
Current ratio1.4
Debt/Equity0.6
ROA3.6%
ROE9.2%
Cash conversion3.3%
CapEx/Revenue-5.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricBESAActivity
Op margin8.7%0.4% medp25 -8.0% · p75 16.0%above median
Net margin3.9%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin28.3%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-5.4%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity63.0%59.0% medp25 54.9% · p75 72.9%above median
Observations
IR observations
market data ESG controversies score100.0
market data ESG governance pillar40.3
market data ESG social pillar31.7
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 06:55 UTC#153cf4f4
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 06:57 UTCJob: 93988159